MORGAN STANLEY PLC/CALL/CVS HEALTH/81/0.1/20.12.24 Stock

Warrant

DE000MB33SZ8

Market Closed - Börse Stuttgart 14:34:07 2024-07-01 EDT
0.06 EUR -6.25% Intraday chart for MORGAN STANLEY PLC/CALL/CVS HEALTH/81/0.1/20.12.24
Current month-4.48%
1 month+48.84%
Date Price Change
24-07-01 0.06 -6.25%
24-06-28 0.064 +12.28%
24-06-27 0.057 -19.72%
24-06-26 0.071 -4.05%
24-06-25 0.074 -13.95%

Delayed Quote Börse Stuttgart

Last update July 01, 2024 at 02:34 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
Issuer Morgan Stanley
WKN MB33SZ
ISINDE000MB33SZ8
Date issued 2023-02-01
Strike 81 $
Maturity 2024-12-20 (172 Days)
Parity 10 : 1
Emission price 1.77
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.81
Lowest since issue 0.032
Delta0.11x
Omega 9.497
Premium40.4x
Gearing90.24x
Moneyness 0.7179
Difference Strike 22.85 $
Difference Strike %+28.21%
Spread 0.002
Spread %3.28%
Theoretical value 0.0600
Implied Volatility 35.15 %
Total Loss Probability 93.10 %
Intrinsic value 0.000000
Present value 0.0600
Break even 81.64 €
Theta-0x
Vega0.01x
Rho0x

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
58.15 USD
Average target price
69.1 USD
Spread / Average Target
+18.82%
Consensus